Cargando…

Inherited and Acquired Determinants of Hepatic CYP3A Activity in Humans

Human CYP3A enzymes (including CYP3A4 and CYP4A5) metabolize about 40% of all drugs and numerous other environmental and endogenous substances. CYP3A activity is highly variable within and between humans. As a consequence, therapy with standard doses often results in too low or too high blood and ti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Matthaei, Johannes, Bonat, Wagner Hugo, Kerb, Reinhold, Tzvetkov, Mladen Vassilev, Strube, Jakob, Brunke, Stefanie, Sachse-Seeboth, Cordula, Sehrt, Daniel, Hofmann, Ute, von Bornemann Hjelmborg, Jacob, Schwab, Matthias, Brockmöller, Jürgen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7472781/ https://www.ncbi.nlm.nih.gov/pubmed/32973880 http://dx.doi.org/10.3389/fgene.2020.00944

Ejemplares similares

Low heritability in pharmacokinetics of talinolol: a pharmacogenetic twin study on the heritability of the pharmacokinetics of talinolol, a putative probe drug of MDR1 and other membrane transporters
por: Matthaei, Johannes, et al.
Publicado: (2016)

Effects of Genetic Polymorphism in CYP2D6, CYP2C19, and the Organic Cation Transporter OCT1 on Amitriptyline Pharmacokinetics in Healthy Volunteers and Depressive Disorder Patients
por: Matthaei, Johannes, et al.
Publicado: (2021)

Effects of genetic polymorphisms on the OCT1 and OCT2-mediated uptake of ranitidine
por: Meyer, Marleen Julia, et al.
Publicado: (2017)

Isobutyrylcarnitine as a Biomarker of OCT1 Activity and Interspecies Differences in its Membrane Transport
por: Jensen, Ole, et al.
Publicado: (2021)

Highly Variable Pharmacokinetics of Tyramine in Humans and Polymorphisms in OCT1, CYP2D6, and MAO-A
por: Rafehi, Muhammad, et al.
Publicado: (2019)

Pharmacogenetics: data, concepts and tools to improve drug discovery and drug treatment
por: Brockmöller, Jürgen, et al.
Publicado: (2008)

Impact of Promoter Polymorphisms on the Transcriptional Regulation of the Organic Cation Transporter OCT1 (SLC22A1)
por: Bokelmann, Kristin, et al.
Publicado: (2018)

Physiologically Based Pharmacokinetic Modeling to Describe the CYP2D6 Activity Score-Dependent Metabolism of Paroxetine, Atomoxetine and Risperidone
por: Rüdesheim, Simeon, et al.
Publicado: (2022)

Oral Yohimbine as a New Probe Drug to Predict CYP2D6 Activity: Results of a Fixed-Sequence Phase I Trial
por: Vay, Manuela, et al.
Publicado: (2020)

Effects of a Common Eight Base Pairs Duplication at the Exon 7-Intron 7 Junction on Splicing, Expression, and Function of OCT1
por: Römer, Sarah, et al.
Publicado: (2021)

Data‐driven personalization of a physiologically based pharmacokinetic model for caffeine: A systematic assessment
por: Fendt, Rebekka, et al.
Publicado: (2021)

A double-Flp-in method for stable overexpression of two genes
por: Jensen, Ole, et al.
Publicado: (2020)

Amino acids in transmembrane helix 1 confer major functional differences between human and mouse orthologs of the polyspecific membrane transporter OCT1
por: Meyer, Marleen J., et al.
Publicado: (2022)

Comparing Salivary Caffeine Kinetics of (13)C and (12)C Caffeine for Gastric Emptying of 50 mL Water
por: Grimm, Michael, et al.
Publicado: (2023)

Global genetic analyses reveal strong inter-ethnic variability in the loss of activity of the organic cation transporter OCT1
por: Seitz, Tina, et al.
Publicado: (2015)

Cloning and Functional Characterization of Dog OCT1 and OCT2: Another Step in Exploring Species Differences in Organic Cation Transporters
por: Meyer, Marleen Julia, et al.
Publicado: (2022)

In Vivo Evaluation of a Gastro-Resistant HPMC-Based “Next Generation Enteric” Capsule
por: Rump, Adrian, et al.
Publicado: (2022)

In Vivo Evaluation of a Gastro-Resistant Enprotect(®) Capsule under Postprandial Conditions
por: Grimm, Michael, et al.
Publicado: (2023)

Molecular Mechanisms of Inherited Arrhythmias
por: Wolf, Cordula M, et al.
Publicado: (2008)

Familial Risk and Heritability of Hematologic Malignancies in the Nordic Twin Study of Cancer
por: Clemmensen, Signe B., et al.
Publicado: (2021)

Intraperitoneal Chemotherapy of Peritoneal Carcinomatosis Using Pressurized Aerosol as an Alternative to Liquid Solution: First Evidence for Efficacy
por: Solass, Wiebke, et al.
Publicado: (2013)

OCT1 Polyspecificity—Friend or Foe?
por: Meyer, Marleen J., et al.
Publicado: (2021)

The clinically relevant CYP2C8*3 and CYP2C9*2 haplotype is inherited from Neandertals
por: Haeggström, Sigrid, et al.
Publicado: (2022)

Translational learning from clinical studies predicts drug pharmacokinetics across patient populations
por: Krauss, Markus, et al.
Publicado: (2017)

Comparison of In Vitro and In Vivo Results Using the GastroDuo and the Salivary Tracer Technique: Immediate Release Dosage Forms under Fasting Conditions
por: Sager, Maximilian, et al.
Publicado: (2019)

Prediction of Drug–Drug–Gene Interaction Scenarios of (E)-Clomiphene and Its Metabolites Using Physiologically Based Pharmacokinetic Modeling
por: Kovar, Christina, et al.
Publicado: (2022)

CYP2B6 Functional Variability in Drug Metabolism and Exposure Across Populations—Implication for Drug Safety, Dosing, and Individualized Therapy
por: Langmia, Immaculate M., et al.
Publicado: (2021)

Knuckle lesions in inherited and acquired disorders
por: Adya, Keshavmurthy A., et al.
Publicado: (2021)

Editorial: Acquired and Inherited Cardiac Arrhythmias
por: Ben-Haim, Yael, et al.
Publicado: (2022)

Epigenetic signature of birth weight discordance in adult twins
por: Tan, Qihua, et al.
Publicado: (2014)

Inherited and acquired alterations in development of breast cancer
por: Rizzolo, Piera, et al.
Publicado: (2011)

Acquired somatic variants in inherited myeloid malignancies
por: Armes, Hannah, et al.
Publicado: (2022)

Role of TGF-β signaling in inherited and acquired myopathies
por: Burks, Tyesha N, et al.
Publicado: (2011)

piRNA-mediated transgenerational inheritance of an acquired trait
por: Grentzinger, Thomas, et al.
Publicado: (2012)

Inherited and acquired disorders of myelin: The underlying myelin pathology
por: Duncan, Ian D., et al.
Publicado: (2016)

Clinical Impact of Inherited and Acquired Genetic Variants in Mastocytosis
por: Nedoszytko, Boguslaw, et al.
Publicado: (2021)

Epigenetic inheritance of acquired traits through DNA methylation
por: Zhang, Ying, et al.
Publicado: (2021)

Immune complications and their management in inherited and acquired bleeding disorders
por: Arruda, Valder R., et al.
Publicado: (2022)

Editorial: Inherited and acquired ribosomopathies: missing puzzle pieces
por: Valli, Roberto, et al.
Publicado: (2023)

The Inheritance of Mutilations and Other Inheritances
por: Worthington, S. M.
Publicado: (1897)

Cannot write session to /tmp/vufind_sessions/sess_er4f8tgsl3namd6gvrteb8vi63